ETHINYL ESTRADIOL; NORETHINDRONE ACETATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for ethinyl estradiol; norethindrone acetate and what is the scope of freedom to operate?
Ethinyl estradiol; norethindrone acetate
is the generic ingredient in fifty-nine branded drugs marketed by Xiromed, Wilshire Pharms Inc, Amneal Pharms, Dr Reddys Labs Sa, Glenmark Pharms Ltd, Apil, Millicent Pr, Aurobindo Pharma, Lupin Ltd, Teva Pharms Usa Inc, Endo Operations, Novast Labs, Teva Branded Pharm, Lupin, Barr Labs Inc, Apotex, Glenmark Speclt, Barr, and Parke Davis, and is included in seventy-four NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.Ethinyl estradiol; norethindrone acetate has nine patent family members in seven countries.
Twenty-six suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
International Patents: | 9 |
US Patents: | 1 |
Tradenames: | 59 |
Applicants: | 19 |
NDAs: | 74 |
Finished Product Suppliers / Packagers: | 26 |
Clinical Trials: | 13 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
DailyMed Link: | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE at DailyMed |
Recent Clinical Trials for ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Virginia | Early Phase 1 |
Ironwood Pharmaceuticals, Inc. | Phase 1 |
National Institutes of Health (NIH) | Phase 3 |
See all ETHINYL ESTRADIOL; NORETHINDRONE ACETATE clinical trials
Generic filers with tentative approvals for ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Applicant | Application No. | Strength | Dosage Form |
⤷ Sign Up | ⤷ Sign Up | 0.01MG,0.01MG;1MG,N/A | TABLET;ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Drug Class | Estrogen Progestin |
Mechanism of Action | Estrogen Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Paragraph IV (Patent) Challenges for ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LO LOESTRIN FE | Tablets | ethinyl estradiol; norethindrone acetate | 1 mg/0.01 mg, 0.01 mg and 75 mg | 022501 | 1 | 2011-04-29 |
US Patents and Regulatory Information for ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Expired US Patents for ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Apil | MINASTRIN 24 FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 203667-001 | May 8, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Apil | LO MINASTRIN FE | ethinyl estradiol; norethindrone acetate | TABLET, CHEWABLE, TABLET;ORAL | 204654-001 | Jul 24, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Teva Branded Pharm | LOESTRIN 24 FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 021871-001 | Feb 17, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Apil | ESTROSTEP 21 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-21 | 020130-001 | Oct 9, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hong Kong | 1205468 | 延長的雌激素定量給藥避孕療法 (EXTENDED ESTROGEN DOSING CONTRACEPTIVE REGIMEN) | ⤷ Sign Up |
Canada | 2605299 | REGIME CONTRACEPTIF DE DOSAGE D'ESTROGENES ETENDU (EXTENDED ESTROGEN DOSING CONTRACEPTIVE REGIMEN) | ⤷ Sign Up |
European Patent Office | 1877062 | REGIME CONTRACEPTIF DE DOSAGE D STROGENES ETENDU (EXTENDED ESTROGEN DOSING CONTRACEPTIVE REGIMEN) | ⤷ Sign Up |
China | 104248639 | Extended estrogen dosing contraceptive regimen | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1214076 | 49/2008 | Austria | ⤷ Sign Up | PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON; REGISTRATION NO/DATE: 1-27586 20080612 |
1380301 | 2009C/007 | Belgium | ⤷ Sign Up | PRODUCT NAME: DROSPIRENONE-ETHINYLESTRADIOL; AUTHORISATION NUMBER AND DATE: BE321386 20080811 |
0771217 | 07C0001 | France | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804 |
0136011 | 2000C/027 | Belgium | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.